Pure Global
NCT06419504

The Effect of Ultrasonography-guided Fascial Plane Blocks in Breast Cancer Surgery Patients

The Effect of Ultrasonography-guided Pectoserratus Plane Block, Erector Spina Plane Block and Serratus Anterior Plane Block on Postoperative Opioid Consumption, Recovery Quality and Chronic Pain in Breast Cancer Surgery Patients
Antalya Training and Research Hospital·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Breast Cancer
Drug/Device/Intervention
SAP block group
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Antalya Training and Research Hospital
Location
Antalya, Turkey
Timeline & enrollment
Phase
N/A
Start date
May 17, 2024
End date
Nov 15, 2024
Enrollment
96 participants
Primary outcome

postoperative opioid consumption

Summary

The aim of this study was to evaluate the efficacy of serratus anterior plane (SAP) block,
 pectoserratus plane (PECS II) block, and erector spinae plane (ESP) block on postoperative
 acute pain, quality of recovery and chronic pain in breast cancer surgery patients.

ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06419504
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06419504 through Pure Global AI's free database. This phase not specified trial is sponsored by Antalya Training and Research Hospital and is currently Recruiting. The study focuses on Breast Cancer. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.